<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39402752</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1447-0756</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>14</Day></PubDate></JournalIssue><Title>The journal of obstetrics and gynaecology research</Title><ISOAbbreviation>J Obstet Gynaecol Res</ISOAbbreviation></Journal><ArticleTitle>Early pregnancy SARS-COV-2 infection and fetal cardiac and hemodynamic changes.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/jog.16118</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">Our objective was to investigate the impact on fetal cardiac function and fetal hemodynamics after recovery from severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection in early pregnancy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective study involving 60 women in pregnancy who had recovered from a previous SARS-CoV-2 infection and 20 control wemen was performed. Between 11 and 14 weeks of pregnancy, women recovering from infection and controls underwent fetal ultrasound evaluation. Ultrasound parameters assessing cardiac function (TAPSE, MAPSE, E/A ratio) and hemodynamics (DV/S, DV-D, DV-A, DV-TAMV, DV-PI, DV-PLI, DV-PVIV) were measured.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Based on ultrasound measurements, the median gestation age of the groups recovering from SARS-CoV-2 infection (RSI) was 12 (0.5) weeks, while the control group's was 12 (0.7) weeks (p = 0.76). The RSI group and the control group didn't indicate statistically significant differences in ultrasound measurements of cardiac function and hemodynamics (p &gt; 0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">According to our findings, the infection of SARS-CoV-2 in early pregnancy has no substantial influence on fetal cardiac function and fetal hemodynamics in pregnant women. However, the effect on mid-pregnancy to late-pregnancy is not yet known. Future studies will help elucidate the overall impact on fetal cardiac function of SARS-CoV-2 infection.</AbstractText><CopyrightInformation>© 2024 Japan Society of Obstetrics and Gynecology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Zi-Hang</ForeName><Initials>ZH</Initials><Identifier Source="ORCID">0009-0009-3586-3993</Identifier><AffiliationInfo><Affiliation>Department of Ultrasound Medicine, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Xiao-Dan</ForeName><Initials>XD</Initials><AffiliationInfo><Affiliation>Department of Ultrasound Medicine, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Shan-Yu</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Ultrasound Medicine, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Ji-Yu</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Jin-Hua</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Ultrasound Medicine, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Lin-Yu</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Department of Ultrasound Medicine, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Dan-Lei</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Department of Ultrasound Medicine, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Ultrasound Medicine, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Ping-Ping</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Ultrasound Medicine, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Tian-An</ForeName><Initials>TA</Initials><Identifier Source="ORCID">0000-0002-7672-8394</Identifier><AffiliationInfo><Affiliation>Department of Ultrasound Medicine, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>J Obstet Gynaecol Res</MedlineTA><NlmUniqueID>9612761</NlmUniqueID><ISSNLinking>1341-8076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS‐CoV‐2</Keyword><Keyword MajorTopicYN="N">fetal cardiac</Keyword><Keyword MajorTopicYN="N">fetus</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">ultrasound</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39402752</ArticleId><ArticleId IdType="doi">10.1111/jog.16118</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Fenizia C, Vanetti C, Rana F, Cappelletti G, Cetin I, Biasin M, et al. SARS‐CoV‐2 vertical transmission during the first trimester of pregnancy in asymptomatic women. Int J Infect Dis. 2022;124:159–163.</Citation></Reference><Reference><Citation>Pomorski M, Trzeszcz M, Matera‐Witkiewicz A, Krupińska M, Fuchs T, Zimmer M, et al. SARS‐CoV‐2 infection and pregnancy: maternal and neonatal outcomes and placental pathology correlations. Viruses. 2022;14(9):2043.</Citation></Reference><Reference><Citation>Poon LC, Leung BW, Ma T, Yu FNY, Kong CW, Lo TK, et al. Relationship between viral load, infection‐to‐delivery interval and mother‐to‐child transfer of anti‐SARS‐CoV‐2 antibodies. Ultrasound Obstet Gynecol. 2021;57(6):974–978.</Citation></Reference><Reference><Citation>Sinaci S, Ocal DF, Seven B, Anuk AT, Besimoglu B, Keven MC, et al. Vertical transmission of SARS‐CoV‐2: a prospective cross‐sectional study from a tertiary center. J Med Virol. 2021;93(10):5864–5872.</Citation></Reference><Reference><Citation>Tan CMJ, Lewandowski AJ. The transitional heart: from early embryonic and fetal development to neonatal life. Fetal Diagn Ther. 2020;47(5):373–386.</Citation></Reference><Reference><Citation>Dubey P, Reddy SY, Manuel S, Dwivedi AK. Maternal and neonatal characteristics and outcomes among COVID‐19 infected women: an updated systematic review and meta‐analysis. Eur J Obstet Gynecol Reprod Biol. 2020;252:490–501.</Citation></Reference><Reference><Citation>Halici‐Ozturk F, Ocal FD, Aydin S, Tanacan A, Ayhan SG, Altinboga O, et al. Investigating the risk of maternal‐fetal transmission of SARS‐CoV‐2 in early pregnancy. Placenta. 2021;106:25–29.</Citation></Reference><Reference><Citation>Turan O, Hakim A, Dashraath P, Jeslyn WJL, Wright A, Abdul‐Kadir R. Clinical characteristics, prognostic factors, and maternal and neonatal outcomes of SARS‐CoV‐2 infection among hospitalized pregnant women: a systematic review. Int J Gynaecol Obstet. 2020;151(1):7–16.</Citation></Reference><Reference><Citation>Shao X, Zhang X, Zhang R, Zhu R, Hou X, Yi W, et al. The atlas of ACE2 expression in fetal and adult human hearts reveals the potential mechanism of heart‐injured patients infected with SARS‐CoV‐2. Am J Physiol Cell Physiol. 2022;322(4):C723–C738.</Citation></Reference><Reference><Citation>Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS‐CoV‐2. Cardiovasc Res. 2020;116(6):1097–1100.</Citation></Reference><Reference><Citation>Kreis NN, Ritter A, Louwen F, Yuan J. A message from the human placenta: structural and immunomodulatory defense against SARS‐CoV‐2. Cells. 2020;9(8):1777.</Citation></Reference><Reference><Citation>Seymen CM. Being pregnant in the COVID‐19 pandemic: effects on the placenta in all aspects. J Med Virol. 2021;93(5):2769–2773.</Citation></Reference><Reference><Citation>Sharps MC, Hayes DJL, Lee S, Zou Z, Brady CA, Almoghrabi Y, et al. A structured review of placental morphology and histopathological lesions associated with SARS‐CoV‐2 infection. Placenta. 2020;101:13–29.</Citation></Reference><Reference><Citation>Akhtar H, Patel C, Abuelgasim E, Harky A. COVID‐19 (SARS‐CoV‐2) infection in pregnancy: a systematic review. Gynecol Obstet Investig. 2020;85(4):295–306.</Citation></Reference><Reference><Citation>Mullins E, Perry A, Banerjee J, Townson J, Grozeva D, Milton R, et al. Pregnancy and neonatal outcomes of COVID‐19: the PAN‐COVID study. Eur J Obstet Gynecol Reprod Biol. 2022;276:161–167.</Citation></Reference><Reference><Citation>Smith ER, Oakley E, Grandner GW, Ferguson K, Farooq F, Afshar Y, et al. Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS‐CoV‐2 infection: an individual participant data meta‐analysis. BMJ Glob Health. 2023;8(1):e009495.</Citation></Reference><Reference><Citation>Chung MK, Zidar DA, Bristow MR, Cameron SJ, Chan T, Harding CV III, et al. COVID‐19 and cardiovascular disease: from bench to bedside. Circ Res. 2021;128(8):1214–1236.</Citation></Reference><Reference><Citation>Helms J, Combes A, Aissaoui N. Cardiac injury in COVID‐19. Intensive Care Med. 2022;48(1):111–113.</Citation></Reference><Reference><Citation>Metzler B, Lechner I, Reindl M, Reinstadler SJ. Cardiac injury after COVID‐19: primary cardiac and primary non‐cardiac etiology makes a difference. Int J Cardiol. 2022;350:17–18.</Citation></Reference><Reference><Citation>Bojkova D, Wagner JUG, Shumliakivska M, Aslan GS, Saleem U, Hansen A, et al. SARS‐CoV‐2 infects and induces cytotoxic effects in human cardiomyocytes. Cardiovasc Res. 2020;116(14):2207–2215.</Citation></Reference><Reference><Citation>Han Y, Zhu J, Yang L, Nilsson‐Payant BE, Hurtado R, Lacko LA, et al. SARS‐CoV‐2 infection induces ferroptosis of sinoatrial node pacemaker cells. Circ Res. 2022;130(7):963–977.</Citation></Reference><Reference><Citation>Koźlik M, Błahuszewska A, Kaźmierski M. Cardiovascular system during SARS‐CoV‐2 infection. Int J Environ Res Public Health. 2022;19(3):e1343.</Citation></Reference><Reference><Citation>Yang Y, Wei Z, Xiong C, Qian H. Direct mechanisms of SARS‐CoV‐2‐induced cardiomyocyte damage: an update. Virol J. 2022;19(1):108.</Citation></Reference><Reference><Citation>Rizzo G, Mappa I, Pietrolucci ME, Lu JLA, Makatsarya A, D'Antonio F. Effect of SARS‐CoV‐2 infection on fetal umbilical vein flow and cardiac function: a prospective study. J Perinat Med. 2022;50(4):398–403.</Citation></Reference><Reference><Citation>Rizzo G, Mappa I, Maqina P, Bitsadze V, Khizroeva J, Makatsarya A, et al. Effect of SARS‐CoV‐2 infection during the second half of pregnancy on fetal growth and hemodynamics: a prospective study. Acta Obstet Gynecol Scand. 2021;100(6):1034–1039.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>